TRADING UPDATES: MediaZest virus hit; SpaceandPeople Network Rail deal
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read moreFri, 16th Oct 2020 09:30
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Read morePhysiomics PLC - oncology consultancy based in Oxford, England - Non-Executive Chair Paul Harper steps down from board immediately, having served on the board since 2004 and as chair since 2007. Chief Executive Officer Jim Millen will take on the additional role of executive chair. Physiomics also will recruit one independent non-executive director "as soon as possible".
Read morePhysiomics PLC - oncology consultancy based in Oxford - Confirms it will continue to collaborate with DoseMeRx, after Tabula Rasa Healthcare Inc announces it will sell DoseMeRx. The collaboration will explore further commercial opportunities in cancer field. Over 2021, Physiomics' personalised dosing application for docetaxel prostate cancer treatment was integrated into DoseMeRx platform, and was met with positive feedback.
Read moreTRADING UPDATES: Mercia buys more Intechnica; Anexo scores VW win
Read moreIN BRIEF: Physiomics signs new deals with Merck worth GBP300,000
Read more(Sharecast News) - Oncology consulting company Physiomics announced on Monday that it has signed new agreements with its existing client Merck with a total value of £0.3m.
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: Physiomics pens further deals with Merck KGaA
Read more(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it had been awarded two further contracts by existing client Merck.
Read moreEARNINGS UPDATES: Northbridge "delighted"; Echo Energy loss narrows
Read moreUK earnings, trading statements calendar - next 7 days
Read moreIN BRIEF: Physiomics recruits first patient for Partner study
Read moreTRADING UPDATES: Arkle spots gold; SDCL seals USD177 million buy
Read moreAIM WINNERS & LOSERS: Arkle finds gold; Staffline raises cash
Read more(Sharecast News) - Oncology drug development consultancy Physiomics said on Friday that it has been awarded two further contracts by existing client Bicycle Therapeutics.
Read more